Literature DB >> 1649552

Detection of herpes simplex virus using the polymerase chain reaction followed by endonuclease cleavage.

B B Rogers1, S L Josephson, S K Mak.   

Abstract

The polymerase chain reaction (PCR) was used to amplify herpes simplex virus DNA using a single set of primers that amplify both herpes simplex virus I (HSVI) and II (HSVII). The viruses can be differentiated by a single restriction enzyme cleavage. Virus from dilutions of HSV-infected A549 cell suspensions were amplified and the infectivity endpoints of cell culture were compared with the PCR, and with another direct detection method, the enzyme-linked immunosorbent assay (ELISA). The PCR was capable of detecting virus at a 10(-4) dilution for both HSVI and HSVII, when the corresponding TCID50 endpoints were 10(-5.9) and 10(-5.7), respectively. The ELISA detected virus only down to the 10(-1) dilution. The amplification procedure showed the greatest sensitivity when an initial protease digestion was followed by filtration. The PCR may have use in detection of HSV in clinical situations in which a rapid result is desirable.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649552      PMCID: PMC1886141     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

Review 1.  The polymerase chain reaction: miracle or mirage? A critical review of its uses and limitations in diagnosis and research.

Authors:  P A Wright; D Wynford-Thomas
Journal:  J Pathol       Date:  1990-10       Impact factor: 7.996

2.  Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis.

Authors:  A H Rowley; R J Whitley; F D Lakeman; S M Wolinsky
Journal:  Lancet       Date:  1990-02-24       Impact factor: 79.321

Review 3.  Chlamydia, group B streptococcus, and herpes in pregnancy.

Authors:  R L Sweet
Journal:  Birth       Date:  1985       Impact factor: 3.689

4.  Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population.

Authors:  W E Lafferty; S Krofft; M Remington; R Giddings; C Winter; A Cent; L Corey
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

5.  Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction.

Authors:  B B Rogers; L C Alpert; E A Hine; G J Buffone
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

6.  Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification.

Authors:  G J Demmler; G J Buffone; C M Schimbor; R A May
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

7.  Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme.

Authors:  S L Brice; D Krzemien; W L Weston; J C Huff
Journal:  J Invest Dermatol       Date:  1989-07       Impact factor: 8.551

8.  Polymerase chain reaction and viral culture techniques to detect HSV in small volumes of cerebrospinal fluid; an experimental mouse encephalitis study.

Authors:  R H Boerman; E P Arnoldus; A K Raap; B R Bloem; M Verhey; G van Gemert; A C Peters; M van der Ploeg
Journal:  J Virol Methods       Date:  1989-08       Impact factor: 2.014

9.  Rapid diagnosis of herpes simplex virus infections by enzyme-linked immunosorbent assay.

Authors:  S A Land; I J Skurrie; G L Gilbert
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

10.  Monoclonal antibodies for rapid diagnosis and typing of genital herpes infections during pregnancy.

Authors:  A Volpi; A D Lakeman; L Pereira; S Stagno
Journal:  Am J Obstet Gynecol       Date:  1983-08-01       Impact factor: 8.661

View more
  12 in total

1.  Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test.

Authors:  A P Cullen; C D Long; A T Lörincz
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Specialized functional properties of the integrin alpha 4 cytoplasmic domain.

Authors:  P D Kassner; R Alon; T A Springer; M E Hemler
Journal:  Mol Biol Cell       Date:  1995-06       Impact factor: 4.138

3.  Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.

Authors:  K Hayashi; W G Chen; Y Y Chen; I Murakami; H L Chen; N Ohara; S Nose; K Hamaya; S Matsui; M M Bacchi; C E Bacchi; K L Chang; L M Weiss
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

4.  Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.

Authors:  E Fikrig; H Tao; F S Kantor; S W Barthold; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Long-term protection of mice from Lyme disease by vaccination with OspA.

Authors:  E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Epstein-Barr virus in gastric carcinoma.

Authors:  M Tokunaga; C E Land; Y Uemura; T Tokudome; S Tanaka; E Sato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

7.  Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice.

Authors:  E Fikrig; S W Barthold; N Marcantonio; K Deponte; F S Kantor; R A Flavell
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Inhibition of PCR by aqueous and vitreous fluids.

Authors:  D L Wiedbrauk; J C Werner; A M Drevon
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

9.  Epstein-Barr virus-associated gastric adenocarcinoma.

Authors:  D Shibata; L M Weiss
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

10.  Detection of infectious agents in brain of patients with acute hemorrhagic leukoencephalitis.

Authors:  Shu F An; Michael Groves; Lillian Martinian; Lu T Kuo; Francesco Scaravilli
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.